These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 7713573)

  • 1. Use of liposome preparation to treat mycobacterial infections.
    Bermudez LE
    Immunobiology; 1994 Oct; 191(4-5):578-83. PubMed ID: 7713573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Diagnosis and treatment of mycobacterial infections in patients with HIV/AIDS].
    Pulido F; Iribarren JA; Kindelan JM; Moreno S
    Enferm Infecc Microbiol Clin; 1998; 16 Suppl 1():20-8. PubMed ID: 9859616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical experience with rifabutin in the treatment of mycobacterial infections.
    De Cian W; Sassella D; Wynne BA
    Scand J Infect Dis Suppl; 1995; 98():22-6. PubMed ID: 8867175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The bacteriology of tuberculosis and non-tuberculosis mycobacterial infections].
    Wyplosz B; Truffot-Pernot C; Robert J; Jarlier V; Grosset J
    Rev Mal Respir; 1997 Dec; 14 Suppl 5():S33-48. PubMed ID: 9496590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mycobacterial skin disease: approaches to therapy.
    Gart GS; Forstall GJ; Tomecki KJ
    Semin Dermatol; 1993 Dec; 12(4):352-6. PubMed ID: 8312151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mycobacterial infections.
    Peloquin CA
    Pharmacotherapy; 1993; 13(6):634-9. PubMed ID: 8302690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New tuberculosis drug development. How can we do better?
    O'Brien RJ; Vernon AA
    Am J Respir Crit Care Med; 1998 Jun; 157(6 Pt 1):1705-7. PubMed ID: 9620895
    [No Abstract]   [Full Text] [Related]  

  • 10. On the development of mycobacterial infections II. Changing mycobacterial infection spectrum in the Cologne area 1983-1993.
    Schütt-Gerowitt H
    Zentralbl Bakteriol; 1995 Dec; 283(2):225-38. PubMed ID: 8825114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Manifestations, diagnosis and treatment of non-tuberculous mycobacterial infections in patients with HIV infection].
    Payen MC; De Wit S; Clumeck N
    Rev Mal Respir; 1997 Dec; 14 Suppl 5():S142-51. PubMed ID: 9496599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Azithromycin and Mycobacterium avium infection].
    Perronne C
    Pathol Biol (Paris); 1995 Jun; 43(6):565-7. PubMed ID: 8539084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diagnosis and treatment of tuberculosis or Mycobacterium avium-intracellulare complex infection in HIV-infected patients].
    Shirasaka T
    Kekkaku; 2007 Nov; 82(11):845-8. PubMed ID: 18078110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mycobacterial infection in Mexican AIDS patients.
    Molina-Gamboa JD; Ponce-de-León S; Sifuentes-Osornio J; Bobadilla del Valle M; Ruiz-Palacios GM
    J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Jan; 11(1):53-8. PubMed ID: 8528733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disseminated infection with Simiae-Avium group mycobacteria in persons with AIDS--Thailand and Malawi, 1997.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2002 Jun; 51(23):501-2. PubMed ID: 12079246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Managing HIV. Part 5: Treating secondary outcomes. 5.15 HIV and non-tuberculous mycobacterial infection.
    Hoy JF; Marriott D; Gottlieb T
    Med J Aust; 1996 May; 164(9):543-5. PubMed ID: 8649292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted drug delivery to enhance efficacy and shorten treatment duration in disseminated Mycobacterium avium infection in mice.
    de Steenwinkel JE; van Vianen W; Ten Kate MT; Verbrugh HA; van Agtmael MA; Schiffelers RM; Bakker-Woudenberg IA
    J Antimicrob Chemother; 2007 Nov; 60(5):1064-73. PubMed ID: 17846106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diagnosis, therapy and prognosis of atypical mycobacterial infections--results of a retrospective study].
    Probst G; Apfel T; Schulz V; Petzoldt D; Wiebel M; Ebert W
    Pneumologie; 1994 Sep; 48(9):711-7. PubMed ID: 7800676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [New drugs against tuberculosis and nontuberculous mycobacterial infections: a review].
    Amitani R; Kuze F
    Kekkaku; 1994 Nov; 69(11):711-7. PubMed ID: 7837725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mycobacterial infections following bone marrow transplantation: a 20 year retrospective review.
    Roy V; Weisdorf D
    Bone Marrow Transplant; 1997 Mar; 19(5):467-70. PubMed ID: 9052913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.